Introduction
Epilepsy is a major public health problem affecting around 1% of the population worldwide. Temporal lobe epilepsy (TLE) is the most common epileptic syndrome in adults, and is frequently associated with difficult control seizures. Its etiopathogenesis is complex, involving both genetic and environmental factors. Taking into account their role in plastic or structural changes in several organs, experimental studies have focused on the involvement of inflammatory mechanisms in epilepsy (Silveira et al., 2012; Dedeurwaerdere et al., 2012; Vezzani, 2005; Vezzani and Granata, 2005) .
Inflammation has generally been regarded as harmful to the brain as local (microglia) and infiltrating immune cells (CD4 + and CD8 + T cells), as well as pro-inflammatory cytokines, such as interleukin (IL)-1b, tumor necrosis factor (TNF), and IL-6, may exacerbate neuronal damage in epilepsy (Vezzani, 2005; Liimatainen et al., 2013) . Conversely, there is also evidence supporting a protective role for innate and adaptive immune cells as they can contribute to seizure-suppression in animal models of TLE (Ravizza et al., 2005; Zattoni et al., 2011) . Whatever its effect or involvement, a growing body of evidence has supported a role for inflammatory mechanisms in epilepsy. This is mainly supported by the finding of high levels of pro-inflammatory cytokines, such as IL-1b, IL-6 and TNF, in the cerebrospinal fluid (CSF) or blood 
